Cite
1116: A Prognostic Tool to Identify Patients at High Risk of Relapse at 2, 5 and 8 Years after Cystectomy for Transitional Cell Carcinoma (TCC) of the Urinary Bladder: Nomogram Development and Internal Validation.
MLA
Karakiewicz, Pierre I., et al. “1116: A Prognostic Tool to Identify Patients at High Risk of Relapse at 2, 5 and 8 Years after Cystectomy for Transitional Cell Carcinoma (TCC) of the Urinary Bladder: Nomogram Development and Internal Validation.” Journal of Urology, vol. 173, Apr. 2005, p. 303. EBSCOhost, https://doi.org/10.1016/S0022-5347(18)35272-8.
APA
Karakiewicz, P. I., Shariat, S. F., Perrotte, P., Palapattu, G. S., Rogers, C. G., Bastian, P. J., Lotan, Y., Gupta, A., Vazina, A., Gilad, A., Sagalowsky, A. I., Schoenberg, M. P., & Lerner, S. P. (2005). 1116: A Prognostic Tool to Identify Patients at High Risk of Relapse at 2, 5 and 8 Years after Cystectomy for Transitional Cell Carcinoma (TCC) of the Urinary Bladder: Nomogram Development and Internal Validation. Journal of Urology, 173, 303. https://doi.org/10.1016/S0022-5347(18)35272-8
Chicago
Karakiewicz, Pierre I., Shahrokh F. Shariat, Paul Perrotte, Ganesh S. Palapattu, Craig G. Rogers, Patrick J. Bastian, Yair Lotan, et al. 2005. “1116: A Prognostic Tool to Identify Patients at High Risk of Relapse at 2, 5 and 8 Years after Cystectomy for Transitional Cell Carcinoma (TCC) of the Urinary Bladder: Nomogram Development and Internal Validation.” Journal of Urology 173 (April): 303. doi:10.1016/S0022-5347(18)35272-8.